3D Variational-Conditioned GAN for Molecular Probability Distributions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Pharmaceutical research is hindered by the complexity of protein-ligand interactions, where proteins and ligands' large size and numerous possible conformations make predicting interactions computationally intractable.
Innovation Solution
A system and method using three-dimensional variational-conditioned generative adversarial networks to predict valid molecules by seeding a generator from a variational autoencoder and passing it through another variational autoencoder to produce accurate probability distributions of molecular representations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional computational methods are used to predict protein-ligand interactions, then complete and accurate interaction analysis is attempted, but the computational complexity becomes intractable due to the large size and numerous conformations
Solution Approach 1:
The patent segments the complex protein-ligand interaction problem into distinct computational stages: (1) generating discrete ligand conformations using a VAE-GAN framework, (2) sampling conformational space through probability distributions, and (3) evaluating interactions at sampled states. This segmentation transforms an intractable continuous optimization problem into manageable discrete steps, reducing computational complexity while maintaining prediction accuracy.
Solution Approach 2:
The patent applies preliminary action by pre-training the variational autoencoder to learn the manifold of valid ligand conformations before actual interaction prediction. The VAE-GAN framework pre-computes probability distributions over conformational space, allowing the system to quickly sample plausible ligand states during prediction without exhaustively evaluating all possible conformations, thus reducing computational burden while preserving accuracy.
2Reliability
If the number of possible ligand conformations is increased to improve sampling coverage, then the accuracy of interaction prediction improves, but the computational resources required increase significantly
Solution Approach 1:
The patent implements dynamics by using a probabilistic VAE-GAN framework that dynamically adapts the sampling distribution based on learned conformational manifolds. Instead of uniformly sampling all possible conformations, the system dynamically focuses computational resources on high-probability regions of conformational space that are most relevant to protein-ligand interactions, achieving reliable sampling coverage with reduced computational resources.
Solution Approach 2:
The patent changes parameters by transforming the discrete conformation generation problem into a continuous probability distribution framework. By parameterizing ligand conformations through latent variables in the VAE and using the GAN to learn the underlying distribution, the system can efficiently explore conformational space by sampling from the learned distribution rather than exhaustively enumerating all possible discrete conformations, reducing computational resource requirements while maintaining sampling coverage.
Data Source
AI summary
A system and method that produces an accurate probability distribution representative of a target molecule that may be used in pharmacokinetics and analogous applications. A generator is seeded from a variational autoencoder during training and is then used after training in series with a second variational autoencoder to produce the probability distributions from molecular tensors.